M1: SLE Flashcards
Strongest risk factor SLE
Female gender (more common in african than caucasian)
Chronic multisystem inflammatory disease. Associated with abnormalities of immune system. Results from interactions among genetic, hormonal, environmental and immunologic factors. Affects the skin, joints, serous membranes, renal, hematologic & neurologic.
Systemic Lupus Erythematosus
Pathophysiology: Autoimmune reactions directed against constituents of _____________. Antibody response related to ____ & ____ cells.
Cell nucleus & DNA. B & T cells.
SLE Classification Criteria: presence of biopsy proven __________ with ______ or anti-dsDNA antibodies.
Lupus nephritis. ANA.
SLE Classification Criteria: If ____ of the diagnostic criteria, including at least 1 _________ criterion has been satisfied.
Four. Immunologic.
Manifestations for SLE “SOAP BRAIN MD”
Serositis, Oral ulcers, Arthritis, Photosensitivity, Blood disorders, Renal dev’t, Antinuclear antibodies, Immunologic phenomena(dsDNA; anti smith sm antibodies), Neurologic, Malar rash & Discoid rash
Clinical Manifestations: cutaneous vascular lesion, butterfly rash, oral/nasopharyngeal ulcers & alopecia.
Dermatologic
Clinical Manifestations: Polyartharalgia, Arthritis, swan neck fingers, ulnar deviation & subluxation w/ hyperlaxity of joints.
Musculoskeletal
Clinical Manifestations: tachypnea, pleurisy, dysrhythmias, accelerated CAD & pericariditis.
Cardiopulmonary
Clinical Manifestations: ranging from mild proteinuria to glomerulonephritis.
Lupus nephritis Renal
Primary goal of treatment for lupus nephritis
Slowing the progression
Clinical Manifestations: generalized focal seizures, peripheral neuropathy, cognitive dysfunction like disorientation, memory deficits & psychiatric symptoms.
Nervous system
Clinical Manifestations: formation of antibodies against blood cells, anemia & leukopenia.
Hematologic
Clinical Manifestations: increased susceptibility to MO. Fever considered serious.
Infection
Common cause of death for SLE
Infections like PNA
Criteria for Dx of SLE: _____ & _____ rashes.
Malar & Discoid
Criteria for Dx of SLE: oral ______.
Ulcers
Criteria for Dx of SLE: nonerosive. Involvement of two or more joints characterized by tenderness, swelling and effusion.
Arthritis
Criteria for Dx of SLE: pleuritis or pericarditis.
Serositis
Criteria for Dx of SLE: renal disorder
Persistent proteinuria or cellular cast in urine
Criteria for Dx of SLE: neurologic disorder
Seizures/psychosis
Criteria for Dx of SLE: hemolytic anemia, leukopenia, lymphopenia & thrombocytopenia.
Hematologic disorder
Criteria for Dx of SLE: positive LE preparation, anti-DNA antibody, or antibody Sm nuclear antigen or false positive serologic test for syphilis.
Immunologic disorder
Criteria for Dx of SLE: _______ antibody.
Antinuclear
Is a type of antibody directed against the cell’s nuclei. It is present in nearly everybody with active lupus. Commonly use as a screening tool.
Antinuclear Antibody (ANA)
Limitations of ANA: a _______ doesn’t necessarily indicate Lupus. This result is often seem with some other diseases and in smaller percentage of people w/out lupus or other autoimmune disorders. Not enough for lupus diagnosis.
Positive
Screening test
Sensitive
Confirmatory test
Specific
Is also associated with Mixed Connective Tissue Dse & Rheumatoid Arthritis
ANA
Techniques used to detect ANA
Agglutination, Enzyme immunoassay & Immunofluorescence “AEI”
Indirect Immunofluorescence result in ANA: evenly stained (associated with anti-DNA antibody and histones)
Diffuse/Homogenous
Indirect Immunofluorescence result in ANA: stains edge of nuclei(anti-DNA antibody & anti-lamins antibody)
Peripheral
Indirect Immunofluorescence result in ANA: numerous evenly distributed stained within nuclei (anti-RNP or ribonucleoprotein and anti-Smith antibody)
Speckled
Indirect Immunofluorescence result in ANA: stains two or three large fluorescent area within nuclei (anti-RNP antibody)
Nucleolar
Indirect Immunofluorescence result in ANA: stains a discrete speckled pattern d/t anti C antibody.
Centromere
Are a type of antibody directed against phospholipids. Present in up to 60% of people with lupus. A positive test is also used to help identify women with lupus that have certain risks that require preventive treatment and monitoring. Those risk include blood clots, miscarriage or preterm birth.
Antiphospholipid Antibodies
Limitations of Antiphospholipid Antibodies: may also occur in people ____________. Their presence along is not enough for a lupus diagnosis.
Without lupus
Is an antibody directed against a specific protein found in the nucleus. The protein is found in up to 30% of people with lupus. It’s rarely found in people without lupus. So a positive test may help confirm a lupus dx.
Anti-Sm
Limitations of Anti-Sm: up to only 30% of people with lupus have a ___________ test, so relying on this results alone would miss a large majority of people.
Positive Anti Sm
Is a diagnostic/confirmatory test for SLE and has high specificity if present, but has a low sensitivity, it is not enough for a lupus diagnosis and it should be done after a positive screening test.
Anti-Sm
Is a protein directed against double stranded DNA. Between 70% and 90% of people with lupus has a positive anti-dsDNA test. Test is very specific for lupus. Therefore, a positive test can be useful in confirming a dx. The titer or level of antibodies rises as the disease becomes more active. Presence of anti-dsDNA indicates a greater risk for lupus nephritis.
Anti-dsDNA
Limitations of anti-dsDNA: up to ____ of people have a negative test. So a negative test doesn’t mean a person doesn’t have lupus.
25%
dsDNA is found in SLE as well as low titers in
RA & Sjogren sydrome
Are two antibodies that are commonly found together. They are specific against RNA proteins. Associated with neonatal lupus.
Anti-Ro(SSA) & Anti-La(SSB)
Is found anywhere from 24% to 60% of lupus patients. It is also found in 70% of people with another autoimmune disorder called ________.
Anti-Ro. Sjogren’s.
Is found in 35% of people with Sjogren’s syndrome.
Anti-La
In pregnant women, a positive Anti-RO(SSA) or Anti-La(SSB) warns doctor of the need to monitor the _______.
Baby
Limitations of Anti-Ro & Anti-La: Like other antibodies, the fact that the test is not _______ in many people with lupus means it is not used to diagnosis of lupus. Also it is more indicative of _______ than lupus.
Positive. Sjogren.
Is an inflammation of the salivary and lacrimal glands causing dryness of the mouth and eyes. Speckled or diffuse pattern in ANA.
Sjogren’s syndrome
Against antigens in the cytoplasm of neutrophil & monocytes.
Antineutrophil Cytoplasmic Antibodies (ANCA)
Wegener’s disease (60-90%)
c-ANCA
Microscopic polyangitis(50-80%), UC(40-80%) & Chron’s(10-40%)
p-ANCA
Is a protein in the body that can be a marker of inflammation which could be indicative of lupus. Are commonly used especially on the rural area because they are cheaper.
C-Reactive Protein (CRP)
Limitations of CRP: Because there are many causes for an elevated result including _________. The test is not diagnostic for lupus nor can it distinguish a lupus flare from an infection. Also the level of CRP doesn’t directly correlate with lupus disease activity.
Infection
Are involved in inflammation. The test can look for levels of specific complement proteins or total complement. The level of this are often low in patients with active disease, especially kidney disease.
Complement
Limitations of Complement: Like other tests, complement must be taken in the context of ___________ and other test results. A ____ complement in itself is not a diagnostic of lupus.
Clinical findings. Low.
Measures the speed of RBC moving toward the bottom of the test tube. Used as a marker of inflammation which could indicate of lupus activity.
ESR
Limitations of ESR: like CRP, the ESR is not ______ to lupus. Because there are many causes for a positive result, including infection.
Specific
To measure blood levels in different blood cells. Abnormalities in. Lood cell counts, including WBC & blood cells, may occur in people with lupus.
CBC
In CBC, Is found in about 50% of people
Leukopenia & Thrombocytopenia (same with Lupus)
Is a test to assess kidney and liver function. Abnormalities may indicate the development of complications from lupus.
Chemistry panel
Measures how effective the kidneys are at filtering the blood to eliminate waste products. It is conducted on urine collected over a 24hr period.
Measurement of GFR & Proteinuria
Performed on one urine sample. It measures for protein loss, which is an indicator of kidney function.
Protein/Creatinine ratio
Can be used in screening for kidney disease. The presence of protein, RBC, WBC and cellular casts may all indicate kidney disease.
Urinalysis
1 occassion
Leukopenia
1 occasion
Lymphopenia
<100x10^3 cells/uL in the absence of offending medications
Thrombocytopenia